Stocksigma LogoStocksigma Logo

Sudeep Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

■ Revenue: 19,670 (+20.9% YoY | +24.3% QoQ) ■ EBITDA: 7,324 (+32.1% YoY | +33.4% QoQ) ■ EBITDA Margin (%): 37.2 (+314 bps YoY | +254 bps QoQ) ■ PAT: 5,145

Sudeep Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

Sudeep Pharma Ltd · Outcome · 28 Oct 2026, 10:17 pm

Sudeep Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 19,670 (+20.9% YoY | +24.3% QoQ) ■ EBITDA: 7,324 (+32.1% YoY | +33.4% QoQ) ■ EBITDA Margin (%): 37.2 (+314 bps YoY | +254 bps QoQ) ■ PAT: 5,145 (+12.5% YoY | +26.9% QoQ) ■ EPS (INR): 4.59 (+9.3% YoY | +27.9% QoQ) Sudeep Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) Segmental Performance Pharmaceutical, food and nutrition ■ Revenue: 14,250 (+57.5% YoY | +31.4% QoQ) ■ EBIT: 5,512 (+99.2% YoY | +37.7% QoQ) ■ EBIT Margin (%): 38.7 (+811 bps YoY | +176 bps QoQ) Speciality ingredients ■ Revenue: 5,420 (-24.9% YoY | +8.7% QoQ) ■ EBIT: 1,274 (-46.9% YoY | +17.0% QoQ) ■ EBIT Margin (%): 23.5 (-973 bps YoY | +167 bps QoQ)

Original exchange filing (PDF)

More announcements from Sudeep Pharma Ltd

All Sudeep Pharma Ltd announcements